BioSpace News Archive

GEn1E plans to use the novel discovery, which is licensed from University of Maryland, Baltimore to develop therapies for pulmonary, oncology and muscle degenerative diseases.

Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings, services and dip-coating equipment for medical devices, today announced that its HYDAK® UV coating has been approved for a patent by the United States Patent and Trademark Office (USPTO).

Today IMV, part of Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the first wave of category winners of the 2022 IMV ServiceTrak™ Clinical Laboratory Awards.

INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious diseases and treat people with cancer and HPV-associated diseases, announced today that second quarter 2022 financial results will be released after the market close on August 9, 2022.

Nuvaxovid™ is the first protein-based COVID-19 vaccine available for use in adolescents aged 12 through 17 in Australia.

BioCare, Inc., a leading specialty pharmaceutical distribution partner that provides distribution, specialty pharmacy and logistics services, today announced the expansion of its leadership team with the addition of Tom Hart.

Nuvaxovid™ is the first protein-based COVID-19 vaccine approved for use in adolescents in Japan.

Company to Distribute Recent FDA-Approved Treatment for Reducing Bad Cholesterol.

Synthego, the genome engineering company, announced that the company has broken ground on a 20,000-square-foot manufacturing facility designed to accelerate translational and clinical research development timelines for cell and gene therapies to as little as a year.

Aytu BioPharma, Inc. today announced that Chief Executive Officer Josh Disbrow and Chief Financial Officer Mark Oki will participate in the Canaccord Genuity 42nd Annual Growth Conference being held August 8-11, 2022 at the InterContinental Hotel in Boston, MA.